# Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

> **NCT04493359** · PHASE2,PHASE3 · TERMINATED · sponsor: **University of Sao Paulo** · enrollment: 18 (actual)

## Conditions studied

- Covid19
- Angiotensin II Receptor Antagonist Adverse Reaction

## Interventions

- **DRUG:** Renin-angiotensin system inhibitors

## Key facts

- **NCT ID:** NCT04493359
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-25
- **Primary completion:** 2021-09-28
- **Final completion:** 2021-09-28
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Dificulteis in enrolling patients
- **Last updated:** 2021-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04493359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04493359, "Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04493359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*